Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease chronic myeloproliferative disease
Symptom C0836924|thrombocytosis
Sentences 2
PubMedID- 20586925 Background: anagrelide is a selective inhibitor of megakaryocytopoiesis used to treat thrombocytosis in patients with chronic myeloproliferative disorders.
PubMedID- 21312258 myeloproliferative disorders may present with thrombocytosis and/or leukocytosis with symptoms ranging from minor to life-threatening.

Page: 1